Health Care & Life Sciences » Biotechnology | Revive Therapeutics Ltd.

Revive Therapeutics Ltd.

Revive Therapeutics Ltd.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$4.07 M
Shares Outstanding
24.88 M
Public Float
-
Revive Therapeutics Ltd.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.02
Market Cap
CAD5.47 M
Shares Outstanding
35.9 M
Public Float
25.69 M

Profile

Address
5 Director Court
Vaughan Ontario L4L 4S5
Canada
Employees -
Website http://www.revivethera.com
Updated 07/08/2019
Revive Therapeutics Ltd. engages in the research, development, and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets. It identifies and investigate potential therapies targeting the endocannabinoid system, such as cannabinoids. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Vaughan, Canada.

Financials

View All
Created with Highcharts 5.0.14Revive Therapeutics Ltd.Net Income. Fiscal year is July-June. All values CAD Thousands.1 2571 2572 0312 0312 7372 7371 6151 6151 7901 79020142015201620172018050010001500200025003000

William Jackson
Independent Director
Craig Leon
Chairman & Chief Executive Officer